NCT05652023Recruiting
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
Mayo Clinic
Start Date
4/20/2023
Completion Date
12/20/2028
Summary
The purpose of this study is to test a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry to detect abnormal bladder function.
Detailed Description
The purpose of this study is to evaluate the effectiveness of quantitative ultrasound bladder vibrometry (QUBV) as a noninvasive tool for detrusor overactivity assessment and for benign prostatic hyperplasia (BPH) treatment selection. Participants in this study will have a QUBV ultrasound performed at the same time as a urodynamic study that had been ordered as part of their regular clinical care.
Eligibility Criteria
Age Range: 18 years to 90 years
Inclusion Criteria:
* Aim1:
Age \>18 scheduled to undergo UDS for their clinical care for one of the included diagnoses.
-Aim2: Inclusions: Age \>45 scheduled to undergo selective photovaporization of the prostate.
Exclusion Criteria:
* Aim1:Obesity (BMI \>35kg/m2), known neurologic disease impacting bladder function (e.g. spinal cord injury, multiple sclerosis, Parkinson's, prior cerebrovascular accident), previous pelvic radiation therapy, previous radical pelvic surgery (such as for uterine or colorectal cancer), prior bladder surgery (including prostate resection), and pregnant or breast-feeding women.
* Aim2:Obesity (BMI \>35kg/m2), known neurologic disease impacting bladder function (e.g. spinal cord injury, multiple sclerosis, Parkinson's, prior cerebrovascular accident), previous pelvic radiation therapy, previous radical pelvic surgery (such as colorectal cancer).
Conditions
Bladder DysfunctionOveractive BladderBPH With Urinary Obstruction
Locations
Mayo Clinic
Rochester, Minnesota 55905
United States